← Product Code [LPH](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/LPH) · K000207 # POROCOAT PRODIGY HIP PROSTHESIS (K000207) _DePuy Orthopaedics, Inc. · LPH · Feb 4, 2000 · Orthopedic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/LPH/K000207 ## Device Facts - **Applicant:** DePuy Orthopaedics, Inc. - **Product Code:** [LPH](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/LPH.md) - **Decision Date:** Feb 4, 2000 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 888.3358 - **Device Class:** Class 2 - **Review Panel:** Orthopedic - **Attributes:** Therapeutic ## Intended Use Total hip arthroplasty is intended to provide increased patient mobility and reduce pain by replacing the damaged hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. Total hip replacement is indicated in the following conditions: - Severely painful and/or disabled joint from 1. osteoarthritis, traumatic arthritis, rheumatoid arthritis, or congenital hip dysplasia. - 2. Avascular necrosis of the femoral head. - 3. Acute traumatic facture of the femoral head or neck. - 4. Failed previous hip surgery including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement. - 5. Certain cases of ankylosis. The Porocoat® Prodigy™ Hip Stem is indicated for cementless use and fixation by biological tissue ingrowth into the porous coating as well as cemented use and fixation in which the porous coating serves as a means to augment the fixation of the prostheses to the bone cement. ## Device Story Porocoat® Prodigy™ Hip Prosthesis; femoral hip stem for total hip arthroplasty. Manufactured from ASTM F-75 Cobalt-Chromium-Molybdenum alloy; features sintered cobalt-chrome-molybdenum alloy bead porous coating (Porocoat®) for biological fixation or cement augmentation. Designed for use with AML reamers, broaches, and Excel®/AML impactors. Anteverted neck design accepts femoral ball heads (cobalt-chromium-molybdenum alloy or aluminum ceramic). Used in combination with metal-backed acetabular cup and UHMWPe bearing surface. Intended for surgical implantation by orthopedic surgeons to replace damaged hip joint articulation, increase patient mobility, and reduce pain. ## Clinical Evidence No clinical data provided; substantial equivalence based on design, material, and technological similarities to predicate devices. ## Technological Characteristics Material: ASTM F-75 Cobalt-Chromium-Molybdenum alloy. Coating: Sintered cobalt-chrome-molybdenum alloy bead porous coating. Design: Anteverted neck, tapered for femoral ball heads. Compatibility: AML reamers, broaches, Excel®/AML impactors. Fixation: Cementless (biological ingrowth) or cemented. Sterilization: Identical to predicates. ## Regulatory Identification A hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across the joint. This generic type of device has a femoral component made of a cobalt-chromium-molybdenum (Co-Cr-Mo) alloy or a titanium-aluminum-vanadium (Ti-6Al-4V) alloy and an acetabular component composed of an ultra-high molecular weight polyethylene articulating bearing surface fixed in a metal shell made of Co-Cr-Mo or Ti-6Al-4V. The femoral stem and acetabular shell have a porous coating made of, in the case of Co-Cr-Mo substrates, beads of the same alloy, and in the case of Ti-6Al-4V substrates, fibers of commercially pure titanium or Ti-6Al-4V alloy. The porous coating has a volume porosity between 30 and 70 percent, an average pore size between 100 and 1,000 microns, interconnecting porosity, and a porous coating thickness between 500 and 1,500 microns. The generic type of device has a design to achieve biological fixation to bone without the use of bone cement. ## Predicate Devices - Porocoat® Prodigy™ Hip Prosthesis ([K931641](/device/K931641.md)) - Vision AML® Hip Prosthesis ([K953694](/device/K953694.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K 000207 ______________________________________________________________________________________________________________________________________________________________________________ # 510(k) Summary | Name of Sponsor: | DePuy Orthopaedics, Inc.
700 Orthopaedic Drive
Warsaw, Indiana 46581-0988
Est. Reg. No. 1818910 | |----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 510(k) Contact: | Marcia J. Arentz
Senior Regulatory Associate
Phone: (219) 371-4944
FAX: (219) 371-4940 | | Trade Name: | Porocoat® Prodigy™ Hip Prosthesis | | Common Name: | Total Hip Joint Replacement Prosthesis with porous
coating | | Classification: | Class II Device per 21 CFR 888.3358:
Hip joint metal/polymer/metal semi-constrained
porous coated uncemented prosthesis | | Device Product Code: | Code: 87LPH Prosthesis Hip Semi-constrained,
Metal/Polymer, Cemented
No performance standards have been established
under Section 514 of the Federal Food, Drug, and
Cosmetic Act for femoral hip stems. | | Substantially Equivalent Device: | Porocoat® Prodigy™ Hip Prosthesis K931641
Vision AML® Hip Prosthesis
K953694 | | Device Descriptions: | The hip stem is manufactured from ASTM F-75
Cobalt-Chromium-Molybdenum alloy and has a
sintered cobalt-chrome-molybdenum alloy bead
porous coating (Porocoat®) applied to the stem. The
porous coating is applied to the entire stem with the
exception of the tapered stem tip region of all stems
and a modified geometric cut-out area on the medial
aspect of the mid portion of the stem of larger-sized
prostheses. The stem is designed to be used with
AML reamers and broaches and now has been
modified to be used with the Excel®/AML impactor.
The design utilizes an anteverted neck with a taper
for attachment of femoral ball heads. Cobalt-
chromium-molybdenum alloy and aluminum ceramic
femoral ball heads are intended to be used with the
Prodigy Hip prosthesis to provide the femoral
prosthetic articular surface for the total hip
arthroplasty in combination with a porous coated | # 00000000 {1}------------------------------------------------ ## 510(k) Summary (continued) metal backed acetabular cup prosthesis that uses an ultra high molecular weight polyethylene bearing (UHMWPe) surface. Intended use: Total hip arthroplasty is intended to provide increased patient mobility and reduce pain by replacing the damaged hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. > Total hip replacement is indicated in the following conditions: - Severely painful and/or disabled joint from 1. osteoarthritis, traumatic arthritis, rheumatoid arthritis, or congenital hip dysplasia. - 2. Avascular necrosis of the femoral head. - 3. Acute traumatic facture of the femoral head or neck. - 4. Failed previous hip surgery including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement. - న్. Certain cases of ankylosis. The fundamental scientific technologies of the Prodigy Hip Prosthesis have not changed from the FDA cleared Prodigy Hip Prosthesis system (K931641) and the Vision AML Hip System (K953694). The intended use and indications for use of the Prodigy Hip Prosthesis have not changed from the FDA cleared Prodigy Hip Prosthesis system (K931641). The Prodigy hip stem is manufactured from ASTM F-75 Cobalt Chromium Molybdenum alloy as are the Prodigy hip stem cleared in K931641 and the Vision AML Hip System (K953694). With the exception of the minor design modifications, the Prodigy hip stem is identical to the Prodigy hip stem device cleared in K931641. Based on conformance with the design control procedures requirements as specified in 21 CFR 820.30, similarities of design, commonly used materials, identical sterilization processes, the same indications for use and intended use, DePuy believes that the Porocoat Prodigy Hip Prosthesis to be substantially equivalent to the FDA cleared Prodigy Hip Prosthesis system (K931641) and the Vision AML Hip System (K953694). Substantial equivalence: Indications for use: 000007 {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing right, with flowing lines above and below them. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 FEB 4 2000 Ms. Marcia J. Arentz Senior Regulatory Associate DePuy Orthopaedics, Inc. P.O. Box 988 700 Orthopedic Drive Warsaw, Indiana 46581-0988 K000207 Re: > Trade Name: Porocoat® Prodigy™ Hip Prosthesis Regulatory Class: II Product Code: LPH Dated: January 17, 2000 Received: January 24, 2000 Dear Ms. Arentz: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {3}------------------------------------------------ ### Page 2 -- Ms. Marcia J. Arentz This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its tollfree number (800) 638-2041 or at (301) 443-6597, or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Nel R. P. Ogden James E. Acting Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ (000)0 510(k) Number (if known): #### Porocoat® Prodigy™ Hip Prosthesis Device Name: ### Indications for Use: Total hip arthroplasty is intended to provide increased patient mobility and reduce pain by replacing the damaged hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. Total hip replacement is indicated in the following conditions: - A severely painful and/or disabled joint from osteoarthritis, traumatic arthritis, rheumatoid 1. arthritis, or congenital hip dysplasia. - Avascular necrosis of the femoral head. 2. - Acute traumatic fracture of the femoral head or neck. 3. - Failed previous hip surgery including joint reconstruction, internal fixation, arthrodesis, 4. hemiarthroplasty, surface replacement arthroplasty, or total hip replacement. - Certain cases of ankylosis. ડ. The Porocoat® Prodigy™ Hip Stem is indicated for cementless use and fixation by biological tissue ingrowth into the porous coating as well as cemented use and fixation in which the porous coating serves as a means to augment the fixation of the prostheses to the bone cement. Concurrence of CDRH, Office of Device Evaluation *(Division Sign-Off)* Nho br 320 Division of General Restorative Devices 510(k) Number K000207 Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter Use \$\mu_b\$ --- **Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/LPH/K000207](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/LPH/K000207) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com